Biocompatible adipose extracellular matrix and reduced graphene oxide nanocomposite for tissue engineering applications

dc.contributor.authorVerstappen, Kest
dc.contributor.authorKlymov, Alexey
dc.contributor.authorCicuéndez Maroto, Mónica
dc.contributor.authorDa Silva, Daniela M.
dc.contributor.authorBarroca, Nathalie
dc.contributor.authorFernández San Argimiro, Francisco Javier
dc.contributor.authorMadarieta, Iratxe
dc.contributor.authorCasarrubios Molina, Laura
dc.contributor.authorFeito Castellano, María José
dc.contributor.authorDíez Orejas, Rosalía María
dc.contributor.authorFerreira, Rita
dc.contributor.authorLeeuwenburgh, Sander C. G.
dc.contributor.authorPortolés Pérez, María Teresa
dc.contributor.authorMarques, Paula A. A. P.
dc.contributor.authorWalboomers, X. Frank
dc.date.accessioned2024-11-06T19:05:27Z
dc.date.available2024-11-06T19:05:27Z
dc.date.issued2024-04-17
dc.description.abstractDespite the immense need for effective treatment of spinal cord injury (SCI), no successful repair strategy has yet been clinically implemented. Multifunctional biomaterials, based on porcine adipose tissue-derived extracellular matrix (adECM) and reduced graphene oxide (rGO), were recently shown to stimulate in vitro neural stem cell growth and differentiation. Nevertheless, their functional performance in clinically more relevant in vivo conditions remains largely unknown. Before clinical application of these adECM-rGO nanocomposites can be considered, a rigorous assessment of the cytotoxicity and biocompatibility of these biomaterials is required. For instance, xenogeneic adECM scaffolds could still harbour potential immunogenicity following decellularization. In addition, the toxicity of rGO has been studied before, yet often in experimental settings that do not bear relevance to regenerative medicine. Therefore, the present study aimed to assess both the in vitro as well as in vivo safety of adECM and adECM-rGO scaffolds. First, pulmonary, renal and hepato-cytotoxicity as well as macrophage polarization studies showed that scaffolds were benign in vitro. Then, a laminectomy was performed at the 10th thoracic vertebra, and scaffolds were implanted directly contacting the spinal cord. For a total duration of 6 weeks, animal welfare was not negatively affected. Histological analysis demonstrated the degradation of adECM scaffolds and subsequent tissue remodeling. Graphene-based scaffolds showed a very limited fibrous encapsulation, while rGO sheets were engulfed by foreign body giant cells. Furthermore, all scaffolds were infiltrated by macrophages, which were largely polarized towards a pro-regenerative phenotype. Lastly, organ-specific histopathology and biochemical analysis of blood did not reveal any adverse effects. In summary, both adECM and adECM-rGO implants were biocompatible upon laminectomy while establishing a pro-regenerative microenvironment, which justifies further research on their therapeutic potential for treatment of SCI.
dc.description.departmentDepto. de Bioquímica y Biología Molecular
dc.description.departmentDepto. de Microbiología y Parasitología
dc.description.departmentDepto. de Química en Ciencias Farmacéuticas
dc.description.facultyFac. de Farmacia
dc.description.refereedTRUE
dc.description.sponsorshipEuropean Commission
dc.description.statuspub
dc.identifier.citationKest Verstappen, Alexey Klymov, Mónica Cicuéndez, Daniela M. da Silva, Nathalie Barroca, Francisco-Javier Fernández-San-Argimiro, Iratxe Madarieta, Laura Casarrubios, María José Feito, Rosalía Diez-Orejas, Rita Ferreira, Sander C.G. Leeuwenburgh, María Teresa Portolés, Paula A.A.P. Marques, X. Frank Walboomers, Biocompatible adipose extracellular matrix and reduced graphene oxide nanocomposite for tissue engineering applications, Materials Today Bio, Volume 26, 2024, 101059, https://doi.org/10.1016/j.mtbio.2024.101059.
dc.identifier.doi10.1016/j.mtbio.2024.101059
dc.identifier.issn2590-0064
dc.identifier.officialurlhttps://doi.org/10.1016/j.mtbio.2024.101059
dc.identifier.urihttps://hdl.handle.net/20.500.14352/110153
dc.issue.number101059
dc.journal.titleMaterials Today Bio
dc.language.isoeng
dc.page.final15
dc.page.initial1
dc.publisherElsevier
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/829060/EU
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.keywordCytotoxicity
dc.subject.keywordExtracellular matrix
dc.subject.keywordGraphene
dc.subject.keywordNanocomposite
dc.subject.keywordMacrophages
dc.subject.keywordForeign body response
dc.subject.ucmCiencias Biomédicas
dc.subject.unesco24 Ciencias de la Vida
dc.subject.unesco32 Ciencias Médicas
dc.titleBiocompatible adipose extracellular matrix and reduced graphene oxide nanocomposite for tissue engineering applications
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number26
dspace.entity.typePublication
relation.isAuthorOfPublication94b23d40-3b2e-4dad-b72d-96c864251f14
relation.isAuthorOfPublication4d7154a3-79c7-4f0e-ba42-81d562e6e884
relation.isAuthorOfPublication216318f7-e25a-4850-b122-856eb08b3e2f
relation.isAuthorOfPublicatione9388a5d-dfe6-4703-a755-5e10fc0dc5ff
relation.isAuthorOfPublication216318f7-e25a-4850-b122-856eb08b3e2f
relation.isAuthorOfPublication4b317058-0bd1-4fd8-afab-5fa79a4b7002
relation.isAuthorOfPublication.latestForDiscovery94b23d40-3b2e-4dad-b72d-96c864251f14

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Materials Today Bio 2024, 26, 101059.pdf
Size:
20.75 MB
Format:
Adobe Portable Document Format
Description:
Biocompatible adipose extracellular matrix and reduced graphene oxide nanocomposite for tissue engineering applications

Collections